2.4.2.9: uracil phosphoribosyltransferase
This is an abbreviated version!
For detailed information about uracil phosphoribosyltransferase, go to the full flat file.
Word Map on EC 2.4.2.9
-
2.4.2.9
-
5-fluorouracil
-
pyrimidine
-
salvage
-
5-fluorocytosine
-
suicide
-
prodrug
-
orotate
-
bystander
-
5-fluorouridine
-
oncolytic
-
markerless
-
phosphoribosyltransferases
-
counterselectable
-
flucytosine
-
4-thiouracil
-
medicine
-
virotherapy
-
cd/5-fc
-
gene-directed
-
synthesis
-
analysis
-
molecular biology
-
pharmacology
- 2.4.2.9
- 5-fluorouracil
- pyrimidine
-
salvage
- 5-fluorocytosine
-
suicide
-
prodrug
- orotate
-
bystander
- 5-fluorouridine
-
oncolytic
-
markerless
-
phosphoribosyltransferases
-
counterselectable
-
flucytosine
- 4-thiouracil
- medicine
-
virotherapy
-
cd/5-fc
-
gene-directed
- synthesis
- analysis
- molecular biology
- pharmacology
Reaction
Synonyms
AFR052C, AFR052Cp, AGOS_AFR052C, AgUPRT, CD-UPRT, cytosine deaminase-uracil phosphoribosyltransferase, cytosine deaminase/uracil phosphoribosyltransferase, More, MtUPRT, phosphoribosyltransferase, uracil, Rv3309c, TtUPRT, TtUPRT3, UK/UPRT1, UMP pyrophosphorylase, UMP:pyrophosphate phosphoribosyltransferase, UPP, UPRT, UPRTase, uracil phosphoribosyl transferase, uridine 5'-phosphate pyrophosphorylase, uridine kinase-like protein (uracil phosphoribosyltransferase), uridine kinase/uracil phosphoribosyltransferase 1, uridine monophosphate pyrophosphorylase, uridylate pyrophosphorylase, uridylic pyrophosphorylase
ECTree
Advanced search results
Application
Application on EC 2.4.2.9 - uracil phosphoribosyltransferase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
analysis
-
biosynthetic labeling of RNA with uracil phosphoribosyltransferase allows cell-specific microarray analysis of mRNA synthesis and decay
medicine
molecular biology
engineering the yeast fluorocytosine deaminase (FCY1) gene by creating a fusion with the bacterial uracil phosphoribosyl transferase (UPP) gene results in a recombinant protein that converts the precursor 5-fluorocytosine (5-FC) into 5-fluorouracyl, a drug used in the treatment of a range of cancers, which triggers DNA and RNA damage. The tissue-specific FCY-UPP system is a great tool to inactivate cells in a precise spatial and temporal manner, method evaluation, overview
pharmacology
potential target for the development of new antibiotics
synthesis
MtTtUPRT is successfully applied in the enzymatic synthesis of therapeutic NMP analogues. The immobilized enzyme is usable as a biocatalyst in the synthesis of different 5-modified uridine-5'-monophosphates at short times. MTtUPRT3 can be reused up to 8 times in the synthesis of uridine-5'-monophosphate (UMP) with maximum activity at 100°C and pH 7.0 (activity 968 IU/g support, retaining activity 100%). Potential application of MTtUPRT3 as industrial biocatalyst
additional information
medicine
-
combination of 5-flurocytosine/cytosine deaminase-uracil phosphoribosyltransferase with curcumin can be a potential chemosensitization strategy for cancer treatment
medicine
increased expression of UPRT may improve the antitumoral effect of 5-fluorouracil and 5-fluorocytosine, and thereby enhance the potential gene-directed enzyme prodrug therapy
medicine
-
the CD/UPRT construct confers 5-fluorocytosine sensitivity to some pancreatic cell lines
medicine
-
the efficiacy of 5-fluorouracil-based chemotherapy in prostate cancers can be significantly improved by targeted expression of the suicide gene UPRT under the control of the human prostate-specific membrane antigen promotor/enhancer
medicine
-
in presence of 5-fluorocytosine, rat glioblastoma cells C6 and C6r5-FU are sensitive to the cytotoxic effect of human adipose tissue-derived mesenchymal stem cells expressing yeast cytosinedeaminase::uracil phosphoribosyltransferase. The stem cells migrate to glioblastoma cells in vivo and mediate inhibition of glioblastoma growth
medicine
-
the enzyme augments the cancer treatment efficacy of 5-fluorouracil in vitro
medicine
Syrian hamster adenovirus
-
the enzyme increases the sensitivity to 5-fluorouracil in HaP-T1 cells in vitro
MtUPRT is unlikely to be a good target for drugs against Mycobacterium tuberculosis
additional information
-
MtUPRT is unlikely to be a good target for drugs against Mycobacterium tuberculosis
additional information
-
MtUPRT is unlikely to be a good target for drugs against Mycobacterium tuberculosis
-
additional information
-
MtUPRT is unlikely to be a good target for drugs against Mycobacterium tuberculosis
-